asimov.comHealthcareFounded: 2017Funding to Date: $241.8MM
Asimov is a biotech company that specializes in research and development of gene therapies. In addition to the therapies it researches, Asimov provides a technology platform that scientists and geneticists can utilize to research prospective genetic treatments. The private company’s platform contains a genetic informational library and design software for simulation of synthetic biological processes.